Filed under generic version drug

India Allows Compulsory Licensing Of Bayer's Anti-Cancer Drug Sorafenib To NATCO Pharma

India Allows Compulsory Licensing Of Bayer’s Anti-Cancer Drug Sorafenib To NATCO Pharma Article Source: http://techcorplegal.com/Startup_Business/Blog/compulsory_license_india.html Full Article: http://techcorplegal.com/Articles/compulsory_licensing_india.pdf HTML Version: http://biospectrumindia.ciol.com/content/newsAnalysis/11204091.asp Recently, expert opinion of Advocate Rahul Dev, Bioscience Business Lawyer & Patent Attorney, was published in cover story of BioSpectrum India. The globally watched case related to an Indian pharma company’s request to the … Continue reading